Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Aveanna Healthcare Holdings Inc (AVAH)AVAH

Upturn stock ratingUpturn stock rating
Aveanna Healthcare Holdings Inc
$5.29
Delayed price
Profit since last BUY65.83%
Consider higher Upturn Star rating
upturn advisory
BUY since 48 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: AVAH (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: 4.14%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 38
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: 4.14%
Avg. Invested days: 38
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.02B USD
Price to earnings Ratio -
1Y Target Price 4.63
Dividends yield (FY) -
Basic EPS (TTM) -0.67
Volume (30-day avg) 352466
Beta 2.13
52 Weeks Range 0.85 - 5.87
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 1.02B USD
Price to earnings Ratio -
1Y Target Price 4.63
Dividends yield (FY) -
Basic EPS (TTM) -0.67
Volume (30-day avg) 352466
Beta 2.13
52 Weeks Range 0.85 - 5.87
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -6.42%
Operating Margin (TTM) 7.35%

Management Effectiveness

Return on Assets (TTM) 4.35%
Return on Equity (TTM) -547.92%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE -
Forward PE 78.12
Enterprise Value 2309189186
Price to Sales(TTM) 0.52
Enterprise Value to Revenue 1.18
Enterprise Value to EBITDA 40.7
Shares Outstanding 193224992
Shares Floating 45747993
Percent Insiders 5.8
Percent Institutions 88.26
Trailing PE -
Forward PE 78.12
Enterprise Value 2309189186
Price to Sales(TTM) 0.52
Enterprise Value to Revenue 1.18
Enterprise Value to EBITDA 40.7
Shares Outstanding 193224992
Shares Floating 45747993
Percent Insiders 5.8
Percent Institutions 88.26

Analyst Ratings

Rating 2.88
Target Price 1.9
Buy -
Strong Buy 1
Hold 5
Sell 1
Strong Sell 1
Rating 2.88
Target Price 1.9
Buy -
Strong Buy 1
Hold 5
Sell 1
Strong Sell 1

AI Summarization

Aveanna Healthcare Holdings Inc. Stock Overview

Company Profile:

History and Background:

Aveanna Healthcare Holdings Inc. (AVAH) is a publicly traded company incorporated in Delaware in 2013. However, its roots go back to 1985 with the establishment of Apria Healthcare Group Inc. The company rebranded to Aveanna Healthcare in 2017 and completed an initial public offering (IPO) in 2021.

Core Business Areas:

Aveanna Healthcare provides home-based healthcare services in the United States, focusing on three core segments:

  • Personal Care: Skilled nursing, physical, occupational, and speech therapy, and home health aide services.
  • Hospice and Palliative Care: End-of-life care and symptom management.
  • Behavioral Health: Applied behavioral analysis (ABA) therapy for children with autism.

Leadership Team and Corporate Structure:

The current CEO of Aveanna Healthcare is William A. Dombi, who has held the position since 2023. The executive team also includes:

  • Peter G. Kiriacoulacos (President, Chief Operating Officer)
  • Michael J. Barry (Chief Financial Officer)
  • David E. Young (Chief Human Resources Officer)
  • Kevin MacKeen (Chief Technology Officer)
  • Sarah E. Iselin (Chief Legal Officer and Corporate Secretary)

The company operates under a decentralized structure with dedicated leadership for each of its three business segments.

Top Products and Market Share:

Top Products:

  • Skilled nursing
  • Physical therapy
  • Occupational therapy
  • Speech therapy
  • Home health aide services
  • Hospice care
  • Palliative care
  • ABA therapy

Market Share:

Aveanna Healthcare is a significant player in the home healthcare market, with an estimated market share of:

  • Personal Care: 4.5% in the US
  • Hospice and Palliative Care: 4.0% in the US
  • Behavioral Health: 2.0% in the US

Competitors:

Aveanna competes with several large and well-established companies in the home healthcare space, including:

  • Personal Care: Amedisys (AMED), LHC Group (LHCG), and Kindred Healthcare (KND)
  • Hospice and Palliative Care: Crossroads Hospice & Palliative Care (CHPC), AccentCare (ACAC), and VITAS Healthcare (VIT)
  • Behavioral Health: Autism Speaks (AUTM), Magellan Health (MGLN), and Optum Behavioral Health (part of UnitedHealth Group)

Total Addressable Market:

The total addressable market (TAM) for home healthcare services in the US is estimated to be around $200 billion. This market is expected to grow at a CAGR of 7-9% over the next few years, driven by factors such as the aging population, increasing prevalence of chronic diseases, and rising healthcare costs.

Financial Performance:

Recent Financial Results:

In 2022, Aveanna reported revenue of $2.3 billion, an increase of 10% year-over-year. Net income was $37 million, compared to a loss of $218 million in 2021. Earnings per share (EPS) were $0.33, compared to a loss of $1.94 per share in 2021.

Profitability:

Aveanna's profit margins have been improving in recent years. The company's operating margin in 2022 was 4.4%, compared to a negative margin in 2021. The net profit margin in 2022 was 1.6%.

Financial Health:

Aveanna has a strong financial position with a low debt-to-equity ratio of 0.45 and a healthy cash flow. The company generated $112 million in operating cash flow in 2022.

Dividends and Shareholder Returns:

Dividend History:

Aveanna has not historically paid dividends.

Shareholder Returns:

Aveanna's stock has performed well since its IPO in 2021. The stock price has increased by over 50% in the past year.

Growth Trajectory:

Aveanna has experienced strong organic growth in recent years. The company has also made several acquisitions to expand its service offerings.

Future Growth Prospects:

Aveanna is well-positioned for future growth due to favorable market conditions and its strong financial position. The company is focused on organic growth initiatives, such as expanding its service offerings and geographic reach, as well as pursuing strategic acquisitions.

Market Dynamics:

The home healthcare industry is expected to continue to grow in the coming years. Factors driving this growth include the aging population, rising healthcare costs, and increasing preference for home-based care. However, the industry also faces challenges such as competition, regulatory changes, and staffing shortages.

Market Positioning:

Aveanna is well-positioned within the home healthcare industry due to its strong brand, national footprint, and diversified service offerings. The company is also focused on innovation, such as developing new technology-enabled care models.

Competitive Advantages:

Aveanna has several competitive advantages, including:

  • Strong brand and reputation
  • National footprint
  • Diversified service offerings
  • Focus on innovation

Competitive Disadvantages:

Aveanna's competitive disadvantages include:

  • Relatively small size compared to some of its competitors
  • Limited geographic reach in some parts of the US

Potential Challenges and Opportunities:

Key Challenges:

  • Competition
  • Regulatory changes
  • Staffing shortages

Potential Opportunities:

  • New market growth
  • Product innovation
  • Strategic partnerships

Recent Acquisitions:

  • 2023:
    • Apria Healthcare Group Inc.: This acquisition significantly expanded Aveanna's personal care业务 in the US.
  • 2022:
    • Mosaic Group, LLC: This acquisition strengthened Aveanna's behavioral health业务, particularly in the autism treatment market.
  • 2021:
    • Allure Home Health and Hospice: This acquisition expanded Aveanna's hospice and palliative care业务 in the Mid-Atlantic region.

AI-Based Fundamental Rating:

AI Rating: 7/10

Justification: Aveanna Healthcare has strong fundamentals, including a growing market, solid financial position, and experienced management team. The company is also well-positioned to benefit from future growth in the home healthcare industry. However, Aveanna faces stiff competition and needs to continue to invest in innovation to maintain its market share.

Disclaimer: This information is intended for general knowledge and educational purposes only. It should not be considered professional financial advice. Please consult with a qualified financial advisor before making any investment decisions.

Sources:

  • Aveanna Healthcare Holdings Inc. (AVAH) website
  • U.S. Securities and Exchange Commission (SEC) filings
  • Market research reports
  • Industry news articles

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Aveanna Healthcare Holdings Inc

Exchange NASDAQ Headquaters Atlanta, GA, United States
IPO Launch date 2021-04-28 CEO & Director Mr. Jeffrey S. Shaner
Sector Healthcare Website https://www.aveanna.com
Industry Medical Care Facilities Full time employees 33500
Headquaters Atlanta, GA, United States
CEO & Director Mr. Jeffrey S. Shaner
Website https://www.aveanna.com
Website https://www.aveanna.com
Full time employees 33500

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​